Wave Life Sciences to Present at Jefferies Global Healthcare Conference in London
Key Highlights
- ➤Wave Life Sciences to participate in Jefferies Global Healthcare Conference fireside chat
- ➤Fireside chat scheduled for November 18, 2026, at 3:30 p.m. GMT
- ➤Wave’s lead pipeline includes obesity, alpha-1 antitrypsin deficiency, and PNPLA3 programs
Expert Statements
Paul Bolno, President and Chief Executive Officer of Wave Life Sciences
“Reimagine Possible”
CAMBRIDGE, Mass., Nov. 11, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences, Inc. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced that Paul Bolno, MD, MBA, President and Chief Executive Officer, is scheduled to participate in an analyst-led fireside chat at the Jefferies Global Healthcare Conference in London on Wednesday, November 18, 2026 at 3:30 p.m. GMT / 10:30 a.m. ET.
A live webcast of this presentation can be accessed by visiting “Investor Events” on the Investors section of the Wave Life Sciences website: https://ir.wavelifesciences.com/events-publications/events. A replay of this presentation will be archived and available on the site for a limited time following the event.
Get started
Create a free account to read the full story.